Menu Member Login
  • Welcome
  • About MDCSCO
    • Leadership
    • Resources
  • Join
    • Corporate Members
    • Oncology Professionals
  • Calendar of Events
    • Past Meetings
  • News
    • Industry News
    • FDA approvals
  • Contact Us

Search
Search
  • Welcome
  • About MDCSCO
    • Leadership
    • Resources
  • Join
    • Corporate Members
    • Oncology Professionals
  • Calendar of Events
    • Past Meetings
  • News
    • Industry News
    • FDA approvals
  • Contact Us

Corporate Members

       

Quick Links

  • Corporate Members
  • Join
  • Update Profile
  • Resources
  • FDA Approvals

Upcoming Events

Wed Apr 19, 2023Spring Specialty Symposium
Category: Events
Tue May 9, 2023Practice Administrators' Network Free Event
Category: Events
Wed Jun 21, 2023ASCO Update
Category: Events
View Full Calendar

Affiliates

March 2023 Issue

MDCSCO Insights

 

Click here for all current and past issues of Strategies

 


Critical Conversations: A Cancer Learning Series

Click here for series recordings

 


Click here for series recordings

Click here to advertise in Strategies

 

CALL TO ACTION: Clinical Treatment Act Implementation

Beginning on January 1, 2022, all states and territories will be required to cover and reimburse for the routine costs of care for services associated with Medicaid enrollee participation in a qualifying clinical trial. The Center for Medicaid and CHIP Services (CMCS) issued a State Medicaid Director Letter outlining new Medicaid state plan requirements, including what is/is not a covered service, definition of a qualifying clinical trial, coverage determinations, and state exceptions for compliance as presented in the legislation.

CMCS is instructing states to submit a state plan amendment (SPA) describing coverage, benefits, and payment methodology used to pay service providers for routine costs associated with clinical trials in each state. The SPA should be issued at least one day prior to the effective date of the proposed changes. To ensure equitable, transparent, consistent, and comprehensive coverage requirements across all states, ASCO drafted a SPA offering specific and technical coverage and reimbursement recommendations. The SPA is intended to serve as a model submission from state Medicaid agencies to CMCS. We have also attached an accompanying "challenges" document which provides the rationale for the provisions included in the SPA and other implementation considerations.

We urge State Affiliates to send the attached SPA and challenges document to your State Medicaid Agency requesting they consider our recommendations as they draft their own. With the CLINICAL TREATMENT Act effective in less than two weeks, we recommend sending this as soon as possible. Please contact Gina Hoxie at [email protected] with any questions or for additional information.

Oncology News

© Copyright 2023 Maryland/DC Society of Clinical Oncology

574E Ritchie Highway, #271 | Severna Park, MD 21146 | 410-544-7558 | [email protected]
Credit Card Processing Phone Line: 1-855-605-PAID (7243)

    Back to top
    powered by MemberClicks